We are live on
!
Find out more
LSC
Lyon Street Capital Portfolio holdings
AUM
$67M
This Fund
S&P 500
This Quarter
Est. Return
+5.38%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$281M
AUM Growth
-$29.3M
(-9.4%)
Cap. Flow
-$33.1M
Cap. Flow
% of AUM
-11.76%
Top 10 Holdings %
Top 10 Hldgs %
54.92%
Holding
62
New
12
Increased
11
Reduced
29
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SBBP
Strongbridge Biopharma plc.
SBBP
|
+$10.1M |
| 2 |
SGI
Somnigroup International
SGI
|
+$6.55M |
| 3 |
STML
Stemline Therapeutics, Inc.
STML
|
+$4.11M |
| 4 |
QuinStreet
QNST
|
+$3.29M |
| 5 |
QTNA
Quantenna Communications, Inc. Common Stock
QTNA
|
+$2.74M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BFYT
Benefytt Technologies, Inc. Class A Common Stock
BFYT
|
+$7.49M |
| 2 |
BEAT
BioTelemetry, Inc.
BEAT
|
+$5.12M |
| 3 |
RSPP
RSP Permian, Inc.
RSPP
|
+$5.1M |
| 4 |
SCTL
Societal CDMO, Inc. Common Stock
SCTL
|
+$4.77M |
| 5 |
CARB
Carbonite Inc
CARB
|
+$4.48M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.98% |
| 2 | Technology | 19.74% |
| 3 | Financials | 13.45% |
| 4 | Communication Services | 8.08% |
| 5 | Industrials | 5.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CURO
51
DELISTED
CURO Group Holdings Corp.
CURO
| $583K | 0.21% |
+23,367
| New | +$513K |
|
52
Franklin Covey
FC
$245M
| $377K | 0.13% |
+15,363
| New | +$413K |
|
53
Herbalife
HLF
$1.25B
| – | – |
-36,000
| Closed | -$1.75M |
|
|
MCHB
54
Mechanics Bancorp
MCHB
$3.68B
| – | – |
-145,922
| Closed | -$4.18M |
|
55
Ionis Pharmaceuticals
IONS
$9.17B
| – | – |
-69,554
| Closed | -$3.07M |
|
56
Lesaka Technologies
LSAK
$414M
| – | – |
-249,268
| Closed | -$2.36M |
|
57
Twilio
TWLO
$38.2B
| – | – |
-30,500
| Closed | -$1.16M |
|
58
UroGen Pharma
URGN
$2.34B
| – | – |
-32,841
| Closed | -$1.63M |
|
|
CNCE
59
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| – | – |
-11,893
| Closed | -$272K |
|
|
NTUS
60
DELISTED
Natus Medical Inc
NTUS
| – | – |
-17,636
| Closed | -$593K |
|
|
IMMU
61
DELISTED
Immunomedics Inc
IMMU
| – | – |
-252,855
| Closed | -$3.69M |
|
|
RSPP
62
DELISTED
RSP Permian, Inc.
RSPP
| – | – |
-108,693
| Closed | -$5.1M |
|
Similar funds
DCM
SCMU
TLCM
EA
A
AAI
EM
ALFA
Lyon Street Capital's Q2 2018 Portfolio in Review
As of Q2 2018, Lyon Street Capital held 62 positions worth $281M, down 9.4% from $310M the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Lyon Street Capital withdrew a net $33.1M in Q2 2018, closing 10 positions and reducing 29 holdings. Its most notable exit was RSP Permian, Inc., an estimated $5.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 41% a quarter earlier, followed by Technology and Financials.
Against the trend, Lyon Street Capital opened a new position in Somnigroup International worth $6.68M.
- Lyon Street Capital's largest Q2 2018 buy was Somnigroup International: 555,972 shares worth $6.68M.
- Lyon Street Capital added most to Strongbridge Biopharma plc. in Q2 2018, an estimated $10.1M increase.
- Lyon Street Capital's biggest Q2 2018 reduction was Benefytt Technologies, Inc. Class A Common Stock, cutting an estimated $7.49M.
- Lyon Street Capital fully exited RSP Permian, Inc. in Q2 2018, selling an estimated $5.1M.
- Lyon Street Capital's ten largest holdings make up 55% of its $281M portfolio in Q2 2018.
- Lyon Street Capital opened 12 new positions and closed 10 in Q2 2018.
- Lyon Street Capital's portfolio value fell 9.4% quarter-over-quarter to $281M.
Based on Lyon Street Capital's 13F filing for Q2 2018, filed 14 Aug 2018.